Delaware

  • April 17, 2026

    Zales Worker's Age Bias Suit Lacks Evidence, 3rd Circ. Says

    The Third Circuit backed the dismissal of a Zales consultant's bias suit claiming she was fired from the jewelry chain for complaining that her colleagues commented negatively about her age, ruling she couldn't overcome evidence that concerns about her performance actually drove her termination.

  • April 16, 2026

    DC Circ. Ponders If FERC Mistakenly Rejected PJM Deal

    PJM transmission owners faced a skeptical D.C. Circuit Thursday, as aside from saying their arguments were properly preserved in an appeal of the Federal Energy Regulatory Commission rejecting a plan they worked out with regional grid operator PJM Interconnection, they also had to defend the arguments themselves.

  • April 16, 2026

    Village Roadshow Ch. 11 Plan Greenlighted After WB Deal

    Village Roadshow, the film production company behind "The Matrix" and "Ocean's Eleven," won confirmation of its disclosure statement and liquidation plan Thursday after striking a deal with Warner Bros. Entertainment and clearing other objections to smooth its path toward the exits.

  • April 16, 2026

    Trump Depo Bid Can't Justify Trial Delay, Fla. Judge Rules

    A Florida state court judge on Thursday declined to pause a lawsuit over taking Trump Media & Technology Group public, saying the backers of President Donald Trump's Truth Social platform haven't shown good reason to delay a July trial start date while they appeal an order denying their bid to depose the president. 

  • April 16, 2026

    Del. River Regulator Says It Lawfully Extended LNG Permit

    The Delaware River Basin Commission and the developer of a proposed liquefied natural gas export terminal asked a New Jersey federal court to toss a suit alleging the commission wrongly renewed a construction permit for a second time, saying the dispute rests on differing grammatical interpretations.

  • April 16, 2026

    Fed. Circ. Says Judge Wrongly Axed Teva's $177M Eli Lilly Win

    The Federal Circuit ruled Thursday that a Massachusetts federal judge was wrong to overturn a $177 million jury verdict that Teva won against Eli Lilly & Co. on headache drug patents, finding that contrary to the judge's finding, the patents are not invalid.

  • April 16, 2026

    Del. Rejects Fiduciary Claim Over Competing Opioid Clinic

    The Delaware Chancery Court on Thursday largely rejected a healthcare company's claims that a former executive unlawfully competed against it by launching a nearby opioid treatment clinic, finding only a narrow breach of fiduciary duty and awarding just over $1,600 in damages.

  • April 15, 2026

    Amneal Trims But Can't Nix AGs' Drug Price-Fixing Suit

    There is enough evidence from which a jury could conclude that Amneal Pharmaceuticals participated in a conspiracy to fix the price of an epilepsy medication, but not enough to show it participated in the overarching antitrust conspiracy alleged by dozens of state attorneys general, a Connecticut federal judge ruled Wednesday.

  • April 15, 2026

    Payments Co., Owner 'Sabotaged' $175M Sale, Crypto Biz Says

    A cryptocurrency wallet platform seeks to enforce its $175 million deal to purchase a global payments company, accusing the company and its owner of "a blatant, reckless, and improper campaign" to keep the sale from closing.

  • April 15, 2026

    Chancery Trims Liberty Media SiriusXM Deal Suit

    The Delaware Chancery Court has partially trimmed a stockholder challenge to Liberty Media Corp.'s restructuring of its Sirius XM Holdings Inc. stake, dismissing claims against a special committee while allowing others to proceed against directors accused of favoring the company's controller.

  • April 15, 2026

    Cvent Investors Reach $12M Deal To End Take-Private Suit

    Stockholders of cloud-based event management technology provider Cvent Holding Corp. have reached a $12 million settlement with the company, its top brass and its controlling shareholder over claims that they breached their fiduciary duties in connection with the company's $4.6 billion take-private sale to affiliates of Blackstone Inc.

  • April 15, 2026

    NJ Towns Urge 3rd Circ. To Revive Suit Over Housing Law

    A group of New Jersey municipalities and elected officials told the Third Circuit they have Article III standing for their tossed suit against the state government over a 2024 law that they claim unfairly forces them to rezone areas for affordable housing.

  • April 15, 2026

    Penn State Beats Hazing Appeal Over Failed Title IX Claim

    The Third Circuit declined Wednesday to reinstate Pennsylvania State University and its ex-football coach in a hazing lawsuit filed by a former player, ruling a Title IX claim cannot survive because the alleged harassment was not based on the plaintiff's sex.

  • April 15, 2026

    Leo Says Missteps Sank $50M SpaceX Investment In Appeal

    The Delaware Supreme Court on Wednesday grappled with whether a fund manager's handling of a failed $50 million SpaceX investment crossed the line into fiduciary misconduct, as attorneys for both sides clashed over causation, fairness and a controversial $16 million fee award stemming from the dispute.

  • April 15, 2026

    Solar Co. Freedom Forever Hits Ch. 11 With Over $500M Debt

    California-based home solar panel installer Freedom Forever filed for Chapter 11 protection in Delaware bankruptcy court Wednesday with more than $500 million in debt, including $114 million owed to residential solar panel financing firm Mosaic.

  • April 14, 2026

    26 State AGs Urge FTC To Ban Deceptive Rental Fee Tactics

    A bipartisan coalition of 26 state attorneys general led by New Jersey and Colorado are calling on the Federal Trade Commission to adopt a requirement that residential landlords clearly disclose all costs to tenants up front, responding to the agency's notice last month of potential rulemaking to combat hidden rental fees.

  • April 14, 2026

    States Denied Time For Talks To Settle Drug Price-Fixing Suit

    A Connecticut federal judge Tuesday denied a request by dozens of U.S. states to freeze their antitrust case against generic-drug manufacturers, a pause the states argued would allow the parties to focus on settlement talks rather than pending discovery and motion deadlines.

  • April 14, 2026

    Foundation Building Investors Ink $26M Deal Over PE Buyout

    The CEO, controlling investor and board members of specialty building product maker Foundation Building Materials Inc. and others have reached a $26 million settlement with stockholders who challenged the company's $1.4 billion sale to a private equity buyer on claims that the defendants breached their fiduciary duties.

  • April 14, 2026

    Del. Chancery Tosses Jenzabar Suit As Untimely, Defective

    The Delaware Chancery Court has dismissed a stockholder lawsuit against educational software company Jenzabar Inc. and its founder, finding the claims were procedurally flawed, too late and, in some respects, premature.

  • April 14, 2026

    Lead-Plaintiff Fight Comes First In LRN Suit, Chancery Says

    The Delaware Chancery Court signaled Tuesday that it will prioritize sorting out who can lead a long-running stockholder suit against LRN Corp.'s leaders before turning to the merits, as the judge pushed the parties toward a structured path forward after years of procedural detours.

  • April 14, 2026

    3rd Circ. Upholds J&J Injunction Bid Loss In Biosimilar Fight

    The Third Circuit on Tuesday ruled that a Johnson & Johnson subsidiary couldn't justify its bid for an order blocking Samsung Bioepis from paving the way for a Cigna unit to launch a generic version of an anti-inflammatory treatment.

  • April 14, 2026

    Feds Say USDA Can Tie State Funding To Gender Policies

    The U.S. Department of Agriculture defended its move to condition grant funding on compliance with Trump administration policies on gender, women's sports, diversity and immigration, telling a Massachusetts federal judge that states can forgo the funding if they don't want to comply.

  • April 14, 2026

    Delaware Eyes Stablecoin Edge With Banking Law Overhaul

    Delaware lawmakers and industry attorneys say a pair of proposed bills updating the state's banking laws and creating a regulatory framework for payment stablecoins are aimed at ensuring the state remains a leader as financial services evolve, just as it did decades ago with credit card banking and corporate law.

  • April 13, 2026

    Del. Judge Ends 80K Pre-2026 Zantac Cases

    A Delaware state court on Monday dismissed more than 80,000 suits filed before December alleging that Boehringer Ingelheim's discontinued heartburn medication Zantac caused cancer, following a Delaware Supreme Court ruling on admissibility of the plaintiffs' experts.

  • April 13, 2026

    Hikma Tells Justices Cox Ruling Boosts 'Skinny Label' Case

    Hikma Pharmaceuticals USA Inc. told the U.S. Supreme Court on Monday that the justices' recent decision clearing an internet company in a copyright case bolsters the drugmaker's challenge to a patent suit over its generic version of an Amarin Pharma Inc. heart drug.

Expert Analysis

  • 9th Circ. Ruling Evinces Tightening Of Nonmedical Hardship

    Author Photo

    The Ninth Circuit’s recent ruling in Vilchis-Gomez v. Bondi illustrates how a series of immigration decisions are transforming the extreme hardship defense to removal into a de facto medical necessity requirement, but practitioners can push back by continuing to assert long-standing precedents and building comprehensive records, says Abdoul Konare at Konare Law.

  • Del. Justices' Upholding Of SB 21 Gives Cos. Needed Clarity

    Author Photo

    The Delaware Supreme Court's recent unanimous decision in Rutledge v. Clearway Energy — upholding 2025 corporate law amendments enacted through S.B. 21, which clarified safe harbor protections and key terms — may help stem the DExit movement, whose proponents have claimed unpredictability in Delaware courts, say attorneys at Nelson Mullins.

  • Unique Issues Facing Brand-Compounder Patent Litigation

    Author Photo

    Recent litigation and potential enforcement action against Hims & Hers Health raise questions about how compounders and branded pharmaceuticals companies would be positioned in patent litigation as compared to generics companies, which would require strategies different from those that would be used in traditional Hatch-Waxman Act litigation, say attorneys at Morgan Lewis.

  • Series

    Volunteering With Scouts Makes Me A Better Lawyer

    Author Photo

    Serving as an assistant scoutmaster for my son’s troop reaffirmed several skills and principles crucial to lawyering — from the importance of disconnecting to the value of morality, says Michael Warren at McManis Faulkner.

  • Series

    Law School's Missed Lessons: In Court, It's About Storytelling

    Author Photo

    Law school provides doctrine, cases and hypotheticals, but when lawyers step into the courtroom, they must learn the importance of clarity, credibility, memorability and preparation — in other words, how to tell simple, effective stories, say Nicholas Steverson and Danielle Trujillo at Wheeler Trigg, and Lisa DeCaro at Courtroom Performance.

  • How Recent Del. Rulings Clarify M&A Deal Fraud Carveouts

    Author Photo

    Two recent Delaware decisions have provided clarity regarding when a party can or cannot rely on representations made during the course of an M&A transaction, particularly on the scope and enforceability of antireliance provisions, and on representations they knew or should have known were false, says Anthony Boccamazzo at Olshan Frome.

  • High Court's 'Skinny Label' Case May Tackle Wider Questions

    Author Photo

    The U.S. Supreme Court's upcoming decision in Hikma v. Amarin will have important ramifications for broader debates over what defines a generic version of a drug, and the pending case is already altering patent practice, say attorneys at Taft.

  • Aligning Microsoft Tools With NYC Bar AI Recording Guidance

    Author Photo

    The New York City Bar Association’s recently issued formal opinion, providing ethical guidance on artificial intelligence-assisted recording, transcription and summarization, raises immediate questions about data governance and e-discovery for companies that use Microsoft 365 and Copilot, say Staci Kaliner, Martin Tully and John Collins at Redgrave.

  • Where 5th Circ. Ruling Fits In ERISA Arbitration Landscape

    Author Photo

    The Fifth Circuit's recent decision in Parrott v. International Bancshares, holding that an Employee Retirement Income Security Act plan may consent to arbitration, must be understood against the backdrop of a developing body of appellate authority addressing ERISA arbitration, say attorneys at Gibson Dunn.

  • 5 Different AI Systems Raise Distinct Privilege Issues

    Author Photo

    A New York federal court’s recent U.S. v. Heppner decision, holding that a defendant’s use of Claude was not privileged, only addressed one narrow artificial intelligence system, but lawyers must recognize that the spectrum of AI tools raises different confidentiality and privilege questions, says Heidi Nadel at HP.

  • Opinion

    AI-Assisted Arbitration Needs Safeguards To Ensure Fairness

    Author Photo

    As tribunals and arbitral institutions increasingly use artificial intelligence tools in their decision-making processes, ​​​​​​​clear disclosure standards and procedural safeguards are necessary to ensure that efficiency gains do not erode the fairness principles on which arbitration depends, says Alexander Lima at Wesco International.

  • How Del. High Court's Moelis Reversal Fits Into DExit Debate

    Author Photo

    By declining to decide the facial validity of the provisions at issue in Moelis & Co. v. West Palm Beach Firefighters Pension Fund, the Delaware Supreme Court's recent reversal of the Court of Chancery's 2024 ruling highlights broader implications for the ongoing debate over whether companies should incorporate elsewhere, say attorneys at Akin.

  • What's Next After NLRB Dismissal Of SpaceX Suit

    Author Photo

    Though the National Labor Relations Board’s recent decision to dismiss its long-running unfair labor practice complaint against SpaceX on jurisdictional grounds temporarily resolves a circuit split over injunctions, constitutional and employee-classification questions remain, say attorneys at Proskauer.

  • Series

    Playing Piano Makes Me A Better Lawyer

    Author Photo

    Playing piano and practicing law share many parallels relating to managing complexity: Just as hearing an entire musical passage in my head allows me to reliably deliver the message, thinking about the audience's impression helps me create a legal narrative that keeps the reader engaged, says Michael Shepherd at Fish & Richardson.

  • AI-Generated Doc Ruling Guides Attys On Privilege Risks

    Author Photo

    A New York federal court's ruling, in U.S. v. Heppner, that documents created by a defendant using an artificial intelligence tool were not privileged, can serve as a guide to attorneys for retaining attorney-client or work-product privilege over client documents created with AI, say attorneys at Sher Tremonte.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Delaware archive.